KHN senior correspondent Mary Agnes Carey appears on the PBS NewsHour to analyze legislation being considered in the Senate to overhaul the federal health law.
Although some people below the poverty level will now be able to qualify for premium subsidies, they may have trouble covering the out-of-pocket costs.
An expert panel renews its guidelines that children and teens be screened for obesity at doctors’ offices and advised to receive treatment.
Since 2010, at least 79 rural hospitals have closed across the country, and nearly 700 more are at risk of closing. The Republican repeal of the health law could hasten their demise.
The survey also found public support for program changes that would place work requirements on beneficiaries and make drug testing a condition of enrollment.
Experts say the loopholes would allow states to bypass some protections for people with preexisting conditions.
The latest Republican plan to revamp the health law reshapes how age and income affect what help consumers get for paying premiums.
Los republicanos en el Senado revelaron un proyecto de ley de salud que transformaría dramáticamente el programa Medicaid, que ayuda a 70 millones de personas de bajos ingresos a tener cobertura de salud.
Despite promises to craft their own way to revamp the federal health law, the Senate Republican bill follows the House’s lead in many ways.
The public — and most senators — got their first look at the bill as it was released Thursday morning. Here’s a chance to read all 142-pages of it.
Once-fatal childhood diseases, like cystic fibrosis, congenital heart disease and sickle cell anemia, now can be survived into adulthood. But when those patients become too old to see pediatricians, it can be difficult for them to find physicians familiar with their conditions.
The Senate’s version of the American Health Care Act was revealed Thursday. Here’s an insider’s look at the men who drafted it.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
A Washington state woman didn’t find out for months that she was likely infected with the virus that can cause serious birth defects. Clinic officials say they’ll do better.
A small number of medical practices have been moving to “direct primary care,” in which patients pay a monthly retainer for unlimited services. But the collapse of Qliance in Seattle may portend problems with the business model.
A bill pending in the state legislature could make the Golden State the first in the U.S. to open establishments where intravenous drug users can shoot up under medical supervision. Proponents say that would save lives.
No one knows what the final Senate bill will look like — not even those writing it. But here are some safe, educated guesses.
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.”
Critics point to the state’s aggressive eligibility checks as an example of what can go wrong when states have flexibility and add a reason to worry about GOP efforts to overhaul the program.